Sign In
Buy MGTX
$12.52
+0.310 (+2.54%)
At Close: Jul 21, 2026
MeiraGTx (NASDAQ:MGTX) Lowered to Sell at Zacks Investment Research
12:56pm, Sunday, 14'th Nov 2021 Dakota Financial News
Zacks Investment Research downgraded shares of MeiraGTx (NASDAQ:MGTX) from a hold rating to a sell rating in a research report released on Saturday morning, Zacks.com reports. According to Zacks, MeiraGTx Holdings plc focuses on operating as a holding company for MeiraGTx Limited which operates as a clinical stage gene therapy company. It develops novel gene []
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates
10:43am, Wednesday, 10'th Nov 2021
MeiraGTx Holdings PLC (MGTX) delivered earnings and revenue surprises of -13.46% and 38.94%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the st
MeiraGTx to Participate in Upcoming Virtual Investor Conferences
04:30pm, Tuesday, 09'th Nov 2021
LONDON and NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph
Earnings Preview: MeiraGTx Holdings PLC (MGTX) Q3 Earnings Expected to Decline
04:51pm, Thursday, 28'th Oct 2021
MeiraGTx Holdings PLC (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
04:30pm, Tuesday, 28'th Sep 2021
LONDON and NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes,
LONDON and NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced new data from subjects tr
MeiraGTx Reports Second Quarter 2021 Financial and Operational Results
08:00am, Wednesday, 11'th Aug 2021
LONDON and NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Tops Revenue Estimates
10:31am, Tuesday, 11'th May 2021
MeiraGTx Holdings PLC (MGTX) delivered earnings and revenue surprises of -25.58% and 83.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
MeiraGTx Announces Participation at Upcoming Investor Conferences
04:30pm, Wednesday, 05'th May 2021
LONDON and NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, P
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
04:30pm, Monday, 19'th Apr 2021
LONDON and NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, P
MeiraGTx to Present at the 2021 Barclays Global Healthcare Conference
08:30am, Thursday, 04'th Mar 2021
LONDON and NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes,
Earnings Preview: MeiraGTx Holdings PLC (MGTX) Q4 Earnings Expected to Decline
01:38pm, Wednesday, 03'rd Mar 2021
MeiraGTx Holdings PLC (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MeiraGTx: Early Stage Gene Therapy Developer For Eye Diseases
10:07am, Monday, 18'th Jan 2021
MGTX has early proof of concept data for ophthalmic rare disease indications using its gene therapies. It has inked two deals with Janssen, one of them quite lucrative.
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
04:30pm, Wednesday, 16'th Dec 2020
Webcast and conference call to take place on December 17, 2020 at 8:00 a.m. ET Webcast and conference call to take place on December 17, 2020 at 8:00 a.m. ET
MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
04:30pm, Monday, 30'th Nov 2020
LONDON and NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph
